Multicenter phase II trial to assess clinical benefit of zoledronic acid with neo adjuvant endocrine treatment and the relationship between zoledronic acid use and gammadelta T cells for postmenopausal breast cancer.
Phase of Trial: Phase II
Latest Information Update: 29 Jul 2016
Price : $35 *
At a glance
- Drugs Zoledronic acid (Primary) ; Letrozole
- Indications Breast cancer
- Focus Therapeutic Use
- 27 Jul 2016 Status changed from active, no longer recruiting to completed.
- 09 Dec 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan
- 01 Aug 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.